Documents

Documents published by NGOs & Research Organizations

All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines – Oxfam

Working Paper on EU-India FTA – Centad

EU! HANDS OFF OUR MEDICINES – MSF briefing paper

THE TRUTH BEHIND THE SPIN – How the Europe-India Free Trade Agreement will harm access to medicines

The Secret Treaty: Anti-Counterfeit Trade Agreement and Its Impact on Access to Medicines

MSF briefing paper – Data exclusivity in international trade agreements: What consequences for access to medicines?

TABLE OF NAFTA “CHAPTER 11” FOREIGN INVESTOR-STATE CASES AND CLAIMS November 2010

Center for Environmental Law IP EPA Article

Contentious issues in the interim EPAs 

 

Documents published by European Commission

EU-India FTA negotiations and access to medicines Questions and answers

Documents of European Parliament

Draft Common Motion for a Resolution on ACTA

European Parliament resolution of 12 July 2007 on the TRIPS Agreement and access to medicines

Amendments on an EU-India Free Trade Agreement by the Committee on International Trade, European Parliament, 2008

Documents published by WHO

World Health Organization – Data exclusivity and other TRIPS-plus measures

Briefing Note – Access to Medicines: TRIPS, Intellectual Property Rights and Access to Medicines

Public health related TRIPS-plus provisions in bilateral trade agreements